RNAZ TRANSCODE THERAPEUTICS INC Other Situations 8-K Filing 2024 - Annual Meeting of Stockholders Transcode Therapeutics held its 2024 Annual Meeting of Stockholders, where all proposals, including the election of directors and approval of stock plan amendment, were approved.Get access to all SEC 8-K filings of the TRANSCODE THERAPEUTICS INC